71335-2108 Dexamethasone - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71335-2108

Brand Name:

Dexamethasone

Generic Name:

Dexamethasone

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: DEXAMETHASONE

Strength: 4.0

Unit: mg/1

Packages:

Code: 71335-2108-00

Description: 4 TABLET in 1 BOTTLE (71335-2108-0)

Effective Date: May 4, 2023

Discontinued:

Code: 71335-2108-01

Description: 30 TABLET in 1 BOTTLE (71335-2108-1)

Effective Date: Feb. 3, 2023

Discontinued:

Code: 71335-2108-02

Description: 6 TABLET in 1 BOTTLE (71335-2108-2)

Effective Date: June 9, 2022

Discontinued:

Code: 71335-2108-03

Description: 3 TABLET in 1 BOTTLE (71335-2108-3)

Effective Date: Aug. 25, 2022

Discontinued:

Code: 71335-2108-04

Description: 15 TABLET in 1 BOTTLE (71335-2108-4)

Effective Date: Aug. 9, 2022

Discontinued:

Code: 71335-2108-05

Description: 40 TABLET in 1 BOTTLE (71335-2108-5)

Effective Date: April 3, 2024

Discontinued:

Code: 71335-2108-06

Description: 60 TABLET in 1 BOTTLE (71335-2108-6)

Effective Date: April 3, 2024

Discontinued:

Code: 71335-2108-07

Description: 28 TABLET in 1 BOTTLE (71335-2108-7)

Effective Date: Feb. 10, 2023

Discontinued:

Code: 71335-2108-08

Description: 90 TABLET in 1 BOTTLE (71335-2108-8)

Effective Date: April 3, 2024

Discontinued:

Code: 71335-2108-09

Description: 10 TABLET in 1 BOTTLE (71335-2108-9)

Effective Date: Aug. 1, 2022

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Adrenal Glucocorticoid

Minor Class:

Corticosteroid

Orphan Drug Designation:

Status:

In Use